FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221036214> ?p ?o ?g. }

• W4221036214 abstract "Cancer pain is an important factor affecting life quality of patients especially in the advanced stage and relieving pain is one of fundamental strategies for cancer treatment. Opioids such as morphine are the most widely used in clinics. However, they have been reported to be associated with the occurrence and development of several types of cancer. Thus, search for an opioid that has analgesic effect and can retard cancer progress simultaneously is critical for cancer management. In this study, we first examined the expression of μ and κ (MOR and KOR) in cell lines and tumor tissues of hepatocellular carcinoma (HCC), a malignant tumor with high mortality, and then compared the effects of opioid receptors-specific agonists on malignant phenotypes of HCC cells in vitro and tumor growth in an HCC xenograft mouse model. KOR and MOR were found to be highly expressed in HCC cell lines and HCC tissues. The KOR-specific agonist U50488h, oxycodone (agonist for both KOR and MOR) and the MOR-specific agonist morphine inhibited HCC cell proliferation, while only U50488h and oxycodone suppressed colony formation and migration of HCC cells. U50488h and oxycodone, but not morphine, induced HCC apoptosis. Further detection of PERK, GRP78 and CHOP revealed that PERK signaling was upregulated by treatment with U50488h, while treatment with the PERK inhibitor GSK2656157 partially reversed the promotion of apoptosis and inhibition of cell proliferation by U50488h, indicating that endoplasmic reticulum stress is associated with its suppressing effect on HCC malignant phenotypes. Similar to the in vitro results, HCC growth was significantly reduced by administration of U50488h and oxycodone, but not by morphine, in the HCC xenograft mouse model. PERK and caspase-3 in the HCC tissues were up-regulated by U50488h treatment as detected by immunohistochemistry and western blotting. Taken together, our results revealed that activation of KOR by U50488h inhibited malignant phenotypes of HCC both in vitro and in vivo, while activation of MOR by morphine did not have such effect. Because of their dual roles in the relief of pain and in the suppression of malignant phenotypes, opioids such as U50488h that act on KOR should be considered as the first choice for HCC management." @default.
• W4221036214 created "2022-04-03" @default.
• W4221036214 creator A5002923480 @default.
• W4221036214 creator A5012134946 @default.
• W4221036214 creator A5016481316 @default.
• W4221036214 creator A5027584052 @default.
• W4221036214 creator A5045771888 @default.
• W4221036214 creator A5047590453 @default.
• W4221036214 creator A5053204257 @default.
• W4221036214 creator A5069433359 @default.
• W4221036214 creator A5076601235 @default.
• W4221036214 creator A5080308473 @default.
• W4221036214 date "2022-03-31" @default.
• W4221036214 modified "2023-09-29" @default.
• W4221036214 title "Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress" @default.
• W4221036214 cites W1619538507 @default.
• W4221036214 cites W1775284887 @default.
• W4221036214 cites W1891656514 @default.
• W4221036214 cites W1924169910 @default.
• W4221036214 cites W1976370954 @default.
• W4221036214 cites W1976655389 @default.
• W4221036214 cites W1983394428 @default.
• W4221036214 cites W2050008870 @default.
• W4221036214 cites W2083209003 @default.
• W4221036214 cites W2086139880 @default.
• W4221036214 cites W2108802610 @default.
• W4221036214 cites W2137443266 @default.
• W4221036214 cites W2149726778 @default.
• W4221036214 cites W2151003241 @default.
• W4221036214 cites W2152595481 @default.
• W4221036214 cites W2390440968 @default.
• W4221036214 cites W2405437920 @default.
• W4221036214 cites W2736808213 @default.
• W4221036214 cites W2749127872 @default.
• W4221036214 cites W2755763011 @default.
• W4221036214 cites W2789738555 @default.
• W4221036214 cites W2817530895 @default.
• W4221036214 cites W2890283911 @default.
• W4221036214 cites W2900602230 @default.
• W4221036214 cites W2904455780 @default.
• W4221036214 cites W2914391811 @default.
• W4221036214 cites W2947165071 @default.
• W4221036214 cites W2955888829 @default.
• W4221036214 cites W2958594720 @default.
• W4221036214 cites W2997735428 @default.
• W4221036214 cites W3001074970 @default.
• W4221036214 cites W3008472546 @default.
• W4221036214 cites W3008606629 @default.
• W4221036214 cites W3011887437 @default.
• W4221036214 cites W3027113788 @default.
• W4221036214 cites W3080642830 @default.
• W4221036214 cites W3095332916 @default.
• W4221036214 cites W3099817120 @default.
• W4221036214 cites W3103897492 @default.
• W4221036214 cites W3128646645 @default.
• W4221036214 cites W3164090567 @default.
• W4221036214 cites W649191222 @default.
• W4221036214 doi "https://doi.org/10.3389/fonc.2022.844214" @default.
• W4221036214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35433440" @default.
• W4221036214 hasPublicationYear "2022" @default.
• W4221036214 type Work @default.
• W4221036214 citedByCount "1" @default.
• W4221036214 countsByYear W42210362142023 @default.
• W4221036214 crossrefType "journal-article" @default.
• W4221036214 hasAuthorship W4221036214A5002923480 @default.
• W4221036214 hasAuthorship W4221036214A5012134946 @default.
• W4221036214 hasAuthorship W4221036214A5016481316 @default.
• W4221036214 hasAuthorship W4221036214A5027584052 @default.
• W4221036214 hasAuthorship W4221036214A5045771888 @default.
• W4221036214 hasAuthorship W4221036214A5047590453 @default.
• W4221036214 hasAuthorship W4221036214A5053204257 @default.
• W4221036214 hasAuthorship W4221036214A5069433359 @default.
• W4221036214 hasAuthorship W4221036214A5076601235 @default.
• W4221036214 hasAuthorship W4221036214A5080308473 @default.
• W4221036214 hasBestOaLocation W42210362141 @default.
• W4221036214 hasConcept C121608353 @default.
• W4221036214 hasConcept C126322002 @default.
• W4221036214 hasConcept C134018914 @default.
• W4221036214 hasConcept C158617107 @default.
• W4221036214 hasConcept C170493617 @default.
• W4221036214 hasConcept C185592680 @default.
• W4221036214 hasConcept C190283241 @default.
• W4221036214 hasConcept C2776029756 @default.
• W4221036214 hasConcept C2778938600 @default.
• W4221036214 hasConcept C2779886867 @default.
• W4221036214 hasConcept C2781063702 @default.
• W4221036214 hasConcept C502942594 @default.
• W4221036214 hasConcept C55493867 @default.
• W4221036214 hasConcept C62112901 @default.
• W4221036214 hasConcept C71924100 @default.
• W4221036214 hasConcept C86803240 @default.
• W4221036214 hasConcept C95444343 @default.
• W4221036214 hasConcept C96232424 @default.
• W4221036214 hasConcept C98274493 @default.
• W4221036214 hasConceptScore W4221036214C121608353 @default.
• W4221036214 hasConceptScore W4221036214C126322002 @default.
• W4221036214 hasConceptScore W4221036214C134018914 @default.
• W4221036214 hasConceptScore W4221036214C158617107 @default.
• W4221036214 hasConceptScore W4221036214C170493617 @default.
• W4221036214 hasConceptScore W4221036214C185592680 @default.

• next